• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微血管侵犯型肝细胞癌患者术后早期复发预测模型的建立与评估

Establishment and Evaluation of a Predictive Model for Early Postoperative Recurrence of Hepatocellular Carcinoma in Patients with Microvascular Invasion.

作者信息

Zhang Kai, Tao Changcheng, Wu Fan, Siqin Tana, Wu Jianxiong, Rong Weiqi

机构信息

Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100021, People's Republic of China.

出版信息

Int J Gen Med. 2021 Jun 3;14:2259-2274. doi: 10.2147/IJGM.S303896. eCollection 2021.

DOI:10.2147/IJGM.S303896
PMID:34113155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8184236/
Abstract

OBJECTIVE

The present study aimed to identify the risk factors for early postoperative recurrence of hepatocellular carcinoma (HCC) in patients with microvascular invasion (MVI) and develop a predictive model.

INCLUSION POPULATION AND METHODS

Patients who underwent surgery for HCC with pathological identification of MVI at the Cancer Hospital of the Chinese Academy of Medical Sciences from January 2014 to June 2019 were consecutively enrolled in this study. A total of 416 patients were included, divided into an early recurrence group (N = 169) and a non-early recurrence group (N = 247), taking 12 months as the cut-off point for early recurrence. Univariate and multivariate Cox analysis was adopted to screen for risk factors for recurrence, and independence of risk factors was determined by logistic regression analysis. All variables were included in the logistic regression analysis. As previous studies have shown that tumor diameter is a risk factor for recurrence, this was also included in the analyses. A predictive model for early recurrence was established and evaluated.

RESULTS

The results indicate that MVI grouping, preoperative serum AFP, number of tumors, satellite nodules, hepatic capsule invasion, tumor diameter, and lymph node metastasis are independent risk factors for early postoperative recurrence. The above factors were adopted to develop a predictive model. The model had good discrimination and calibration in predicting early postoperative recurrence. Decision curve analysis demonstrated good clinical utility.

CONCLUSION

MVI grouping, preoperative serum AFP, number of tumors, satellite nodules, hepatic capsule invasion, tumor diameter, and lymph node metastasis were shown to be independent risk factors for early postoperative recurrence. The predictive model developed by applying the above risk factors had good predictive value in patients with early postoperative recurrence.

摘要

目的

本研究旨在确定微血管侵犯(MVI)患者肝细胞癌(HCC)术后早期复发的危险因素,并建立预测模型。

纳入人群与方法

2014年1月至2019年6月在中国医学科学院肿瘤医院接受手术治疗且病理确诊为MVI的HCC患者连续纳入本研究。共纳入416例患者,分为早期复发组(N = 169)和非早期复发组(N = 247),以12个月作为早期复发的截断点。采用单因素和多因素Cox分析筛选复发危险因素,并通过逻辑回归分析确定危险因素的独立性。所有变量均纳入逻辑回归分析。由于既往研究表明肿瘤直径是复发的危险因素,因此也将其纳入分析。建立并评估早期复发的预测模型。

结果

结果表明,MVI分组、术前血清甲胎蛋白、肿瘤数量、卫星结节、肝包膜侵犯、肿瘤直径和淋巴结转移是术后早期复发的独立危险因素。采用上述因素建立预测模型。该模型在预测术后早期复发方面具有良好的区分度和校准度。决策曲线分析显示出良好的临床实用性。

结论

MVI分组、术前血清甲胎蛋白、肿瘤数量、卫星结节、肝包膜侵犯、肿瘤直径和淋巴结转移被证明是术后早期复发的独立危险因素。应用上述危险因素建立的预测模型对术后早期复发患者具有良好的预测价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/24c6acbf948a/IJGM-14-2259-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/53086516054a/IJGM-14-2259-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/9e83243f3037/IJGM-14-2259-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/2b714ef7ab4c/IJGM-14-2259-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/77c7f146e618/IJGM-14-2259-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/24c6acbf948a/IJGM-14-2259-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/53086516054a/IJGM-14-2259-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/9e83243f3037/IJGM-14-2259-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/2b714ef7ab4c/IJGM-14-2259-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/77c7f146e618/IJGM-14-2259-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacd/8184236/24c6acbf948a/IJGM-14-2259-g0006.jpg

相似文献

1
Establishment and Evaluation of a Predictive Model for Early Postoperative Recurrence of Hepatocellular Carcinoma in Patients with Microvascular Invasion.微血管侵犯型肝细胞癌患者术后早期复发预测模型的建立与评估
Int J Gen Med. 2021 Jun 3;14:2259-2274. doi: 10.2147/IJGM.S303896. eCollection 2021.
2
Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion.建立、验证和评估伴有微血管侵犯的 R0 切除术后肝癌患者早期复发的预测模型。
J Transl Med. 2021 Jul 6;19(1):293. doi: 10.1186/s12967-021-02940-0.
3
Prediction of Microvascular Invasion and Its M2 Classification in Hepatocellular Carcinoma Based on Nomogram Analyses.基于列线图分析预测肝细胞癌微血管侵犯及其M2分类
Front Oncol. 2022 Jan 14;11:774800. doi: 10.3389/fonc.2021.774800. eCollection 2021.
4
Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.米兰标准内分类的肝细胞癌微血管侵犯的潜在预测因素。
Int J Clin Oncol. 2018 Feb;23(1):98-103. doi: 10.1007/s10147-017-1189-8. Epub 2017 Sep 5.
5
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.米兰标准范围内乙型肝炎病毒相关性肝细胞癌微血管侵犯风险的术前预测列线图。
JAMA Surg. 2016 Apr;151(4):356-63. doi: 10.1001/jamasurg.2015.4257.
6
Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients.一种结合血液学和影像学特征的列线图在肝细胞癌患者微血管侵犯术前预测中的开发与验证
Ann Transl Med. 2021 Mar;9(5):402. doi: 10.21037/atm-20-4695.
7
A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation.肝细胞癌微血管侵犯风险术前评估的列线图:单中心分析及内部验证
Front Oncol. 2021 Mar 4;11:616976. doi: 10.3389/fonc.2021.616976. eCollection 2021.
8
Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma.基于临床数据库的肝癌微血管侵犯预测术前列线图。
Sci Rep. 2021 Jul 7;11(1):13999. doi: 10.1038/s41598-021-93528-7.
9
A Non-Invasive Nomogram for Preoperative Prediction of Microvascular Invasion Risk in Hepatocellular Carcinoma.一种用于术前预测肝细胞癌微血管侵犯风险的非侵入性列线图。
Front Oncol. 2021 Dec 24;11:745085. doi: 10.3389/fonc.2021.745085. eCollection 2021.
10
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.

引用本文的文献

1
A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy.纳入组织病理学和术前钆塞酸增强 MRI 的模型预测根治性肝切除术后无微血管侵犯的肝细胞癌早期复发。
Br J Radiol. 2023 Mar 1;96(1144):20220739. doi: 10.1259/bjr.20220739. Epub 2023 Mar 6.
2
Pre-operative MRI features predict early post-operative recurrence of hepatocellular carcinoma with different degrees of pathological differentiation.术前 MRI 特征可预测不同病理分化程度的肝细胞癌术后早期复发。
Radiol Med. 2023 Mar;128(3):261-273. doi: 10.1007/s11547-023-01601-0. Epub 2023 Feb 10.

本文引用的文献

1
Systemic adjuvant treatment in hepatocellular carcinoma: tempted to do something rather than nothing.肝细胞癌的全身辅助治疗:倾向于采取行动而非无所作为。
Future Oncol. 2020 Nov;16(32):2587-2589. doi: 10.2217/fon-2020-0669. Epub 2020 Aug 8.
2
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌。
N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745.
3
Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
预测根治性肝切除术后肝细胞癌早期和晚期复发的新型预后列线图
Cancer Manag Res. 2020 Mar 9;12:1693-1712. doi: 10.2147/CMAR.S241959. eCollection 2020.
4
Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study.定义和预测肝癌肝切除术后早期复发:多机构研究。
HPB (Oxford). 2020 May;22(5):677-689. doi: 10.1016/j.hpb.2019.09.006. Epub 2019 Oct 10.
5
An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.东方肝胆外科医院微血管侵犯评分系统预测 R0 肝切除术后肝细胞癌伴微血管侵犯患者的预后:一项大样本、多中心研究。
Oncologist. 2019 Dec;24(12):e1476-e1488. doi: 10.1634/theoncologist.2018-0868. Epub 2019 May 28.
6
Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation.微血管侵犯风险对手术和射频消融后肝细胞癌早期复发的影响。
Ann Surg. 2021 Mar 1;273(3):564-571. doi: 10.1097/SLA.0000000000003268.
7
Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.使用放射组学列线图预测适合根治性消融的肝细胞癌早期复发。
Cancer Imaging. 2019 Apr 26;19(1):21. doi: 10.1186/s40644-019-0207-7.
8
A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study.一种用于预测 R0 肝切除术后伴有门静脉癌栓的肝细胞癌早期术后复发的列线图:一项大规模、多中心研究。
Eur J Surg Oncol. 2019 Sep;45(9):1644-1651. doi: 10.1016/j.ejso.2019.03.043. Epub 2019 Apr 3.
9
Nomogram to Assist in Surgical Plan for Hepatocellular Carcinoma: a Prediction Model for Microvascular Invasion.列线图辅助肝细胞癌手术规划:微血管侵犯预测模型。
J Gastrointest Surg. 2019 Dec;23(12):2372-2382. doi: 10.1007/s11605-019-04140-0. Epub 2019 Feb 28.
10
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma.肝细胞癌微血管侵犯的预后和治疗意义。
Ann Surg Oncol. 2019 May;26(5):1474-1493. doi: 10.1245/s10434-019-07227-9. Epub 2019 Feb 20.